Previous Close | 1.4450 |
Open | 1.4000 |
Bid | 1.4000 x 1400 |
Ask | 1.5400 x 1000 |
Day's Range | 1.4000 - 1.5199 |
52 Week Range | 0.8400 - 5.5000 |
Volume | |
Avg. Volume | 108,698 |
Market Cap | 140.01M |
Beta (5Y Monthly) | 1.14 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.4080 |
Earnings Date | Nov 14, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 6.00 |
WIXOM, Mich., December 13, 2022--Rockwell Medical, Inc. ("Rockwell" or the "Company") (Nasdaq: RMTI), a commercial healthcare company focused on providing life-sustaining products for patients suffering from blood disorders and diseases associated with the kidney, announced that the Company is adding new business within the Minnesota region. Rockwell started to supply these clinics with its hemodialysis concentrates products effective December 5, 2022, anticipates that all clinics will be onboar
Rockwell Medical ( NASDAQ:RMTI ) Third Quarter 2022 Results Key Financial Results Revenue: US$18.7m (up 17% from 3Q...
WIXOM, Mich., November 14, 2022--Rockwell Medical, Inc. ("Rockwell" or the "Company") (Nasdaq: RMTI), a commercial healthcare company focused on providing life-sustaining products for patients suffering from blood disorders and diseases associated with the kidney, today provided an update on its overall business strategy and announced its financial and operational results for the third quarter ended September 30, 2022.